Viewing Study NCT07030595

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-01-29 @ 6:44 PM
Study NCT ID: NCT07030595
Status: COMPLETED
Last Update Posted: 2025-11-17
First Post: 2025-06-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
Sponsor: Alebund Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ESRD (End Stage Renal Disease) View
None Chronic Kidney Disease(CKD) View
None Hyperphosphatemia View
None Hyperphosphatemia in Chronic Kidney Disease View
None Dialysis View
None Chronic Kidney Disease, Receiving Dialysis View
Keywords: